The Use of Patient-Derived Tumor Tissue as a Preclinical Tool to Facilitate Identification, Validation and Monitoring of Factors Driving Cancer Development and Progression, Canada
Registration Status: Completed
Objective: Patient tumor samples obtained following standard of care surgical resection will be obtained and clinically annotated. Samples will be used to generate cell lines, organoids, patient-derived explants, or patient-derived xenograft models which will be used for testing of novel anti-cancer or cancer detection agents. Portions of samples will be snap frozen for future use to isolate RNA or protein for subsequent analysis, in addition to fixing a portion in formalin for validation of potential targets of interest by IHC methods.
Registered Biobank Name | The Use of Patient-Derived Tumor Tissue as a Preclinical Tool to Facilitate Identification, Validation and Monitoring of Factors Driving Cancer Development and Progression |
Biobank Leader | Christina Addison |
Country | Canada |
Email for biobank inquiries | caddison@ohri.ca |
Principal Investigator | Christina Addison; Adam Shuhendler |
User Type
|